Regeneron was awarded a $450 million contract through the U.S. government-funded Operation Warp Speed to manufacture and supply REGN-COV2. The COVID-19 antibody cocktail is currently in two Phase 2/3 clinical trials. As a leader in warehouse and inventory management, Yourway can provide the full scope of all biopharmaceutical storage and distribution needs, maximizing efficiency, and decreasing risk on any candidate.